The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Over the past decade, the platelet has emerged as a pivotal entity in cardiovascular
diseases. Indeed, the'preeminence of the platelet'has spawned a variety of drugs that have …

Task Forces, expert groups, or consensus panels. The chosen experts in these writing
panels are asked to provide disclosure statements of all relationships they may have, which …

Objectives: The purpose of this study was to compare the safety and efficacy of
percutaneous coronary intervention (PCI) with stenting against coronary artery bypass …

Background: Patients with diabetes appear to be at elevated risk of atherothrombotic events.
Objectives: The purpose of this study was to determine the effect of antiplatelet therapy with …

Background: Patients with established coronary artery disease or peripheral artery disease
often have diabetes mellitus. These patients are at high risk of future vascular events …

Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

Following an ischemic event, diabetic patients have a higher rate of recurrence than patients
without diabetes mellitus. 1–6 Patients with diabetes but without prior myocardial infarction …

The platelet, once thought to be solely involved in clot formation, is now known to be a key
mediator in various others processes such as inflammation, thrombosis, and atherosclerosis …

Objectives: This study sought to assess the influence of type 2 diabetes mellitus (T2DM) and
the impact of hypoglycemic treatment (insulin vs. noninsulin) on platelet function profiles in …